Skip links

In Congress, deeming reformers welcome FDA’s policy shift

The bipartisan duo attempting to modify the FDA’s deeming regulations in the US Congress reacted with cautious optimism to commissioner Scott Gottlieb’s sweeping new policy plan, which many see as a nod for safer alternatives to traditional tobacco products.

Restricted content. Do you want to read more?